The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

The first clinical trial of its kind found the weekly semaglutide ... increasing to 0.5mg after four weeks. Wegovy is offered for weight management and also has a starting dose of 0.25mg semaglutide ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound. Her weight dropped so much that researchers ...

Then, in May 2022, following reports by celebrities and influencers about blockbuster weight-loss drugs, he decided to go on one himself, and everything changed. He lost 25 pounds the first year ...

In a 72-week study, Zepbound's mean weight loss was 20.2%, while Wegovy's was 13.7%. Amycretin did better in half the time. Novo Nordisk faces at least two issues in the anti-obesity space. First ...

A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...

Semaglutide, sold under the brand names Wegovy for weight loss ... week, found the jabs can dramatically reduce a person's desire for booze - and smokers taking part puffed less. This is the ...

medications used for diabetes and weight loss. The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA's announcement comes ...

an invaluable tool that it can make it much easier to navigate the complicated world of insurance. If you're interested in taking a weight loss drug like Ozempic, Wegovy, or Zepbound ...